Wells Fargo & Company Mimedx Group, Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 70,047 shares of MDXG stock, worth $528,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,047
Previous 180,642
61.22%
Holding current value
$528,154
Previous $1.07 Million
36.93%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MDXG
# of Institutions
231Shares Held
101MCall Options Held
34.6KPut Options Held
36.5K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$213 Million62.7% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$70.2 Million0.0% of portfolio
-
Trigran Investments, Inc.7.62MShares$57.5 Million9.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.71MShares$50.6 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.66MShares$35.2 Million1.25% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $857M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...